Literature DB >> 22802288

Mechanical aspects of lung fibrosis: a spotlight on the myofibroblast.

Boris Hinz1.   

Abstract

Contractile myofibroblasts are responsible for the irreversible alterations of the lung parenchyma that hallmark pulmonary fibrosis. In response to lung injury, a variety of different precursor cells can become activated to develop myofibroblast features, most notably formation of stress fibers and expression of α-smooth muscle actin. Starting as an acute and beneficial repair process, myofibroblast secretion of collagen and contraction frequently becomes excessive and persists. The result is accumulation of stiff scar tissue that obstructs and ultimately destroys lung function. In addition to being a consequence of myofibroblast activities, the stiffened tissue is also a major promoter of the myofibroblast. The mechanical properties of scarred lung and fibrotic foci promote myofibroblast contraction and differentiation. One essential element in this detrimental feed-forward loop is the mechanical activation of the profibrotic growth factor transforming growth factor-β1 from stores in the extracellular matrix. Interfering with myofibroblast contraction and integrin-mediated force transmission to latent transforming growth factor-β1 and matrix proteins are here presented as possible therapeutic strategies to halt fibrosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22802288     DOI: 10.1513/pats.201202-017AW

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  51 in total

Review 1.  Comparative analysis of the mechanical signals in lung development and compensatory growth.

Authors:  Connie C W Hsia
Journal:  Cell Tissue Res       Date:  2017-01-13       Impact factor: 5.249

2.  Matrix stiffness-modulated proliferation and secretory function of the airway smooth muscle cells.

Authors:  Artem Shkumatov; Michael Thompson; Kyoung M Choi; Delphine Sicard; Kwanghyun Baek; Dong Hyun Kim; Daniel J Tschumperlin; Y S Prakash; Hyunjoon Kong
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-02-27       Impact factor: 5.464

3.  Fibrosis on a Chip for Screening of Anti-Fibrosis Drugs.

Authors:  Mohammadnabi Asmani; Ruogang Zhao
Journal:  Methods Mol Biol       Date:  2021

4.  Urokinase Plasminogen Activator Overexpression Reverses Established Lung Fibrosis.

Authors:  Jeffrey C Horowitz; Daniel J Tschumperlin; Kevin K Kim; John J Osterholzer; Natalya Subbotina; Iyabode O Ajayi; Seagal Teitz-Tennenbaum; Ammara Virk; Megan Dotson; Fei Liu; Delphine Sicard; Shijing Jia; Thomas H Sisson
Journal:  Thromb Haemost       Date:  2019-11-08       Impact factor: 5.249

5.  Modulation of human corneal stromal cell differentiation by hepatocyte growth factor and substratum compliance.

Authors:  Hidetaka Miyagi; Iman Jalilian; Christopher J Murphy; Sara M Thomasy
Journal:  Exp Eye Res       Date:  2018-09-05       Impact factor: 3.467

6.  Extracellular matrix type modulates cell migration on mechanical gradients.

Authors:  Christopher D Hartman; Brett C Isenberg; Samantha G Chua; Joyce Y Wong
Journal:  Exp Cell Res       Date:  2017-08-15       Impact factor: 3.905

Review 7.  Tissue-informed engineering strategies for modeling human pulmonary diseases.

Authors:  Kolene E Bailey; Michael L Floren; Tyler J D'Ovidio; Steven R Lammers; Kurt R Stenmark; Chelsea M Magin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-11-21       Impact factor: 5.464

8.  miR-145 regulates myofibroblast differentiation and lung fibrosis.

Authors:  Shanzhong Yang; Huachun Cui; Na Xie; Mert Icyuz; Sami Banerjee; Veena B Antony; Edward Abraham; Victor J Thannickal; Gang Liu
Journal:  FASEB J       Date:  2013-03-01       Impact factor: 5.191

9.  Glycolytic Reprogramming in Myofibroblast Differentiation and Lung Fibrosis.

Authors:  Na Xie; Zheng Tan; Sami Banerjee; Huachun Cui; Jing Ge; Rui-Ming Liu; Karen Bernard; Victor J Thannickal; Gang Liu
Journal:  Am J Respir Crit Care Med       Date:  2015-12-15       Impact factor: 21.405

10.  Substratum compliance modulates corneal fibroblast to myofibroblast transformation.

Authors:  Britta Dreier; Sara M Thomasy; Rima Mendonsa; Vijay Krishna Raghunathan; Paul Russell; Christopher J Murphy
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-28       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.